+ Follow LIPITOR Tag
LIPITOR
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1525356
[Title] => Pfizer, Allergan $160B deal forms world's largest drugmaker
[Summary] => Pfizer and Allergan are joining in the biggest buyout of the year, a $160 billion stock deal that will create the world's largest drugmaker.
[DatePublished] => 2015-11-23 07:47:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[1] => Array
(
[ArticleID] => 872527
[Title] => Ranbaxy recalls generic Lipitor doses
[Summary] => Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once led U.S. regulators to bar imports of the Indian company's medicines.
[DatePublished] => 2012-11-24 01:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[2] => Array
(
[ArticleID] => 825379
[Title] => Retailers sue Pfizer, charge generic Lipitor delay
[Summary] => Five large drug and grocery chains are suing Pfizer Inc. and a second drugmaker, alleging they conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor.
[DatePublished] => 2012-07-07 08:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[3] => Array
(
[ArticleID] => 636390
[Title] => Pfizer CEO Jeffrey Kindler steps down unexpectedly
[Summary] => Jeffrey B. Kindler, the CEO of the world's biggest drugmaker, stepped down Sunday unexpectedly — after less than five years heading Pfizer Inc., a period in which he reorganized most of the company's operations and made an imprint on the industry.
[DatePublished] => 2010-12-06 10:49:11
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[4] => Array
(
[ArticleID] => 607806
[Title] => Detoxing the foodie: Mission impossible?
[Summary] => We all know what it’s like.
[DatePublished] => 2010-09-02 00:00:00
[ColumnID] => 134127
[Focus] => 0
[AuthorID] => 1807758
[AuthorName] => Stephanie Zubiri
[SectionName] => Food and Leisure
[SectionUrl] => food-and-leisure
[URL] => http://a.imageshack.us/img828/2486/lif1thumbm.jpg
)
[5] => Array
(
[ArticleID] => 554987
[Title] => Unilab vs Pfizer: David at Goliath
[Summary] => NAKAKABILIB ang United Laboratories (Unilab), local na tagagawa ng gamot.
[DatePublished] => 2010-03-06 00:00:00
[ColumnID] => 133395
[Focus] => 0
[AuthorID] => 1804793
[AuthorName] => Al G. Pedroche
[SectionName] => PSN Opinyon
[SectionUrl] => opinyon
[URL] =>
)
[6] => Array
(
[ArticleID] => 552870
[Title] => Lipitor vs Avamax
[Summary] => Let me get this straight before I even get to the details. I am not lobbying for any pharmaceutical company, multinational or otherwise.
[DatePublished] => 2010-02-27 00:00:00
[ColumnID] => 133753
[Focus] => 0
[AuthorID] => 1805279
[AuthorName] => Rey Gamboa
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[7] => Array
(
[ArticleID] => 528038
[Title] => 'Evergreening' a blot on cheaper drugs law
[Summary] => President Gloria Arroyo confirmed yesterday her plan — reported last Sunday in Postscript — to run for the congressional seat in the second district of Pampanga now held by her son Juan Miguel (Mikey).
[DatePublished] => 2009-12-01 00:00:00
[ColumnID] => 135304
[Focus] => 0
[AuthorID] => 1804858
[AuthorName] => Federico D. Pascual Jr.
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[8] => Array
(
[ArticleID] => 520756
[Title] => Ipaglaban ang murang gamot
[Summary] => MADALAS dahil sa exclusivity claim ng mga giant multinational drug firms sa ilang brand ng gamot, hindi makagawa ang ibang kompanya ng kahalintulad na gamot sa mas murang halaga.
[DatePublished] => 2009-11-07 00:00:00
[ColumnID] => 133395
[Focus] => 0
[AuthorID] => 1804793
[AuthorName] => Al G. Pedroche
[SectionName] => PSN Opinyon
[SectionUrl] => opinyon
[URL] =>
)
[9] => Array
(
[ArticleID] => 434844
[Title] => Pfizer to buy Wyeth for $68B; cut 8,000 jobs
[Summary] => NEW YORK (AP) – Pfizer Inc. is buying rival drugmaker Wyeth in a $68 billion deal that will increase its revenue by 50 percent, solidify its No. 1 rank in the troubled industry and transform it from a pure pharmaceutical company into a diversified health care giant.
[DatePublished] => 2009-01-27 01:01:51
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
)
)
abtest
November 23, 2015 - 7:47am
November 24, 2012 - 1:00am
December 6, 2010 - 10:49am
January 27, 2009 - 1:01am
